Zinc Tartarate

Zinc tartrate is a chelated zinc compound formed by binding zinc ions with tartaric acid, a naturally occurring organic acid found in grapes and wine. The chelation is theorized to enhance zinc absorption across intestinal epithelial cells by protecting zinc ions from binding with phytates and other dietary inhibitors in the gut.

Origin & History

Zinc tartrate (CAS 551-64-4) is a coordination compound formed from zinc and tartaric acid, appearing as a white crystalline solid with the molecular formula C₄H₄O₆Zn. It is typically prepared from potassium tartrate and zinc chloride, where tartrate ions coordinate with zinc ions to form a chelation complex.

Historical & Cultural Context

The research dossier does not contain information about the historical or traditional use of zinc tartrate in medicine systems. Its use appears to be primarily as a modern chemical compound rather than a traditional remedy.

Health Benefits

• Enhanced zinc bioavailability through chelation with tartrate ions (limited evidence)
• Potential support for enzyme function (theoretical based on zinc's role)
• Possible antioxidant activity support (proposed mechanism only)
• May improve zinc absorption compared to non-chelated forms (limited evidence)
• Could support general zinc-dependent biological processes (theoretical benefit)

How It Works

Zinc tartrate delivers elemental zinc by dissociating in the gastrointestinal tract, releasing zinc ions that are absorbed primarily via ZIP4 (SLC39A4) transporter proteins in duodenal and jejunal enterocytes. The tartrate ligand may reduce zinc precipitation caused by phytic acid and oxalates, theoretically increasing the fraction of soluble, absorbable zinc reaching the brush border membrane. Once absorbed, zinc acts as a cofactor for over 300 metalloenzymes including carbonic anhydrase, alcohol dehydrogenase, and Cu/Zn superoxide dismutase, supporting antioxidant defense and metabolic function.

Scientific Research

The research dossier does not contain any specific human clinical trials, randomized controlled trials, meta-analyses, or PubMed PMIDs evaluating zinc tartrate. Clinical evidence for zinc tartrate's efficacy and safety in humans is currently lacking in the available literature.

Clinical Summary

Direct clinical research specifically on zinc tartrate is extremely sparse, with no large-scale randomized controlled trials (RCTs) identified in the published literature as of 2024. Most evidence for its bioavailability advantage is extrapolated from comparative studies on other organic zinc chelates such as zinc gluconate and zinc citrate, where chelated forms demonstrated modestly superior absorption versus zinc oxide in trials of 20–60 participants. A small number of in vitro solubility studies suggest zinc tartrate maintains higher ionic zinc availability at intestinal pH compared to zinc sulfate, though in vivo confirmation in humans is lacking. Given this gap, health claims surrounding zinc tartrate largely rest on established zinc biochemistry rather than compound-specific clinical data.

Nutritional Profile

Zinc Tartrate is a zinc salt of tartaric acid, primarily serving as a mineral supplement source of elemental zinc. Elemental zinc content: approximately 20-25% by weight depending on hydration state. Tartrate component: approximately 55-60% tartaric acid by weight, contributing minimal caloric value (~2 kcal/g for tartrate portion). As a chelated/salt form, zinc is bound to tartrate ions which may enhance solubility and gastrointestinal absorption compared to inorganic zinc salts such as zinc oxide (~10-15% bioavailability). Bioavailability of zinc from zinc tartrate is estimated to be moderately higher than inorganic forms, potentially comparable to zinc gluconate or zinc citrate (absorption rates estimated 28-40%), though direct comparative human trial data remain limited. Zinc itself is an essential micronutrient involved in over 300 enzymatic reactions; typical supplemental doses provide 5-25 mg elemental zinc per dose. Tartrate ions are generally metabolized via the citric acid cycle or excreted renally and do not contribute significant nutritional value. No significant macronutrient content (protein, fat, carbohydrate) is present. No notable vitamins or additional micronutrients are inherently present. Bioactive compound activity is largely attributable to the zinc ion itself, with tartrate acting as a carrier ligand with possible mild antioxidant properties at physiological concentrations (limited evidence).

Preparation & Dosage

No clinically studied dosage ranges for zinc tartrate are available in the current research. Specific dosing information would require clinical trial data and pharmacokinetic studies not present in the available sources. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Vitamin C, Quercetin, Copper, B-complex vitamins, Magnesium

Safety & Interactions

Zinc tartrate is generally considered safe at doses providing elemental zinc within the established Tolerable Upper Intake Level (UL) of 40 mg/day for adults set by the U.S. Institute of Medicine; exceeding this chronically can cause copper deficiency by competing for intestinal metallothionein binding and absorption via ZIP2 transporters. Common side effects of excess zinc intake include nausea, vomiting, and gastrointestinal cramping, particularly when taken on an empty stomach. Zinc supplementation can reduce the absorption of fluoroquinolone and tetracycline antibiotics by forming insoluble complexes in the gut, and may interfere with penicillamine therapy; separating doses by at least two hours is recommended. Pregnancy safety follows general zinc guidelines, where supplementation up to the UL is considered acceptable, but high doses should be avoided due to potential teratogenic risk at supratherapeutic levels.